In addition, and in line with our previous molecular data, the samples of cHL and non-GCB DLBCL had a higher content of CD8+ T-cells than GCB DLBCL (25% of total cells versus 11% of total cells, p = 0.01) (Figure 2D). This evidence concerns the gene CD8A and diffuse large B-cell lymphoma.